Llido, Ailyn M.
HRN: 21-52-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2022
CEFUROXIME 750MG (VIAL)
07/02/2022
07/08/2022
IV
759ng
Q8 Hours
S/P LTCS
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Non-compliant To Guidelines